Nyxoah Revenue

Nyxoah had revenue of 7.68M EUR in the quarter ending June 30, 2026, with 472.76% growth. This brings the company's revenue in the last twelve months to 21.66M, up 339.14% year-over-year. In the year 2025, Nyxoah had annual revenue of 10.02M with 121.63% growth.

Revenue (ttm)

21.66M EUR

Revenue Growth

+339.14%

P/S Ratio

6.37

Revenue / Employee

140,943 EUR

Employees

154

Market Cap

157.73M USD

Revenue Chart

Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.02M	5.50M	121.63%
Dec 31, 2024	4.52M	173.00K	3.98%
Dec 31, 2023	4.35M	1.26M	40.99%
Dec 31, 2022	3.08M	2.23M	261.97%
Dec 31, 2021	852.00K	783.00K	1,134.78%
Dec 31, 2020	69.00K	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Inogen	354.30M
Neuronetics	155.10M
Quanterix	153.41M
Owlet	114.41M
Electromed	73.78M
LENSAR	60.26M
Apyx Medical	58.42M
MaxCyte	31.05M

Revenue Rankings

NYXH News

4 days ago - Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System - GlobeNewsWire
9 days ago - Nyxoah announces ACCESS study meets primary safety, efficacy endpoints - TheFly
25 days ago - Nyxoah price target lowered to $6 from $11 at Cantor Fitzgerald - TheFly
5 weeks ago - Nyxoah price target lowered to $2.31 from $2.86 at Baird - TheFly
5 weeks ago - Nyxoah price target lowered to $6 from $7 at Piper Sandler - TheFly
5 weeks ago - Nyxoah price target lowered to $4 from $13 at Oppenheimer - TheFly
5 weeks ago - Nyxoah Q2 Earnings Call Highlights - MarketBeat
5 weeks ago - Nyxoah Earnings Call Transcript: Q2 2026 - Transcripts

More News